Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Non-Current Deferred Tax Liability came in at $179.0 million in Q1 2026, up 33.58% year-on-year from $134.0 million in Q1 2025, and up 21.77% quarter-over-quarter from $147.0 million in Q4 2025.
Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Non-Current Deferred Tax Liability across 17 years of filings, most recently posting $179.0 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $179.0 million, up 33.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.0 million (up 33.58% YoY), and the FY2025 annual result was $147.0 million, up 14.84% from the prior year.
- Non-Current Deferred Tax Liability came in at $179.0 million for Q1 2026 at Bausch Health Companies, up from $147.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $552.0 million in Q1 2022 to a low of $128.0 million in Q4 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $179.0 million (2026), against an average of $253.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 66.84% in 2024 and soared 33.58% in 2026, its largest moves.
- Bausch Health Companies' Non-Current Deferred Tax Liability stood at $390.0 million in 2022, then decreased by 1.03% to $386.0 million in 2023, then plunged by 66.84% to $128.0 million in 2024, then rose by 14.84% to $147.0 million in 2025, then grew by 21.77% to $179.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $179.0 million (Q1 2026), $147.0 million (Q4 2025), and $145.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.00 Mn |
| Mar 31, 2026 | 179.00 Mn |
| Dec 31, 2025 | 147.00 Mn |
| Dec 31, 2025 | 147.00 Mn |
| Sep 30, 2025 | 145.00 Mn |
| Sep 30, 2025 | 145.00 Mn |
| Jun 30, 2025 | 144.00 Mn |
| Jun 30, 2025 | 144.00 Mn |
| Mar 31, 2025 | 134.00 Mn |
| Mar 31, 2025 | 134.00 Mn |
| Dec 31, 2024 | 128.00 Mn |
| Dec 31, 2024 | 128.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Jun 30, 2024 | 170.00 Mn |
| Jun 30, 2024 | 170.00 Mn |
| Mar 31, 2024 | 170.00 Mn |
| Mar 31, 2024 | 170.00 Mn |
| Dec 31, 2023 | 386.00 Mn |
| Dec 31, 2023 | 386.00 Mn |